REVVITY, INC Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease)
REVVITY, INC (RVTY) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) of $0 for the 3-month period ending 2025-06-29, per its 10-Q filed 2025-08-05.
Financial Statements › Notes › Fair Value, Assets and Liabilities Measured on Recurring Basis, Unobservable Input Reconciliation
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetPeriodIncreaseDecrease · last filed 2026-02-24
- REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease) for the quarter ending 2025-06-29 was $0.00.
- REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease) for the quarter ending 2025-03-30 was $0.00.
- REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease) for the quarter ending 2024-12-29 was $0.00.
- REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease) for the quarter ending 2024-09-29 was $0.00.
- REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease) for fiscal 2024 was $0.00.
- REVVITY, INC fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, period increase (decrease) for fiscal 2023 was -$1.00M.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Period Increase (Decrease) 12 month as first filed |
|---|---|---|---|---|---|
| 2025-06-29 | $0.00 10-Q · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | $0.00 derived: sum of 3 quarters · filed 2025-08-05 | $0.00 derived: sum of 4 quarters · filed 2025-08-05 | |
| 2025-03-30 | $0.00 10-Q · filed 2025-05-06 | $0.00 derived: sum of 2 quarters · filed 2025-05-06 | $0.00 derived: sum of 3 quarters · filed 2025-05-06 | $0.00 derived: sum of 4 quarters · filed 2025-08-05 | |
| 2024-12-29 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-25 | $0.00 derived: sum of 2 quarters · filed 2025-02-25 | $0.00 derived: sum of 3 quarters · filed 2025-08-05 | $0.00 10-K · filed 2025-02-25 | |
| 2024-09-29 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2025-08-05 | $0.00 10-Q · filed 2024-11-06 | -$1.00M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-06-30 | $0.00 10-Q · filed 2025-08-05 | $0.00 10-Q · filed 2025-08-05 | -$1.00M derived: sum of 3 quarters · filed 2026-02-24 | -$1.00M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2024-03-31 | $0.00 10-Q · filed 2025-05-06 | -$1.00M derived: sum of 2 quarters · filed 2026-02-24 | -$1.00M derived: sum of 3 quarters · filed 2026-02-24 | -$1.00M derived: sum of 4 quarters · filed 2026-02-24 | |
| 2023-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-24 | -$1.00M derived: sum of 2 quarters · filed 2026-02-24 | -$1.00M derived: sum of 3 quarters · filed 2026-02-24 | -$1.00M 10-K · filed 2026-02-24 | -$1.04M 10-K · filed 2024-02-27 |
| 2023-10-01 | $0.00 10-Q · filed 2024-11-06 | $0.00 derived: sum of 2 quarters · filed 2024-11-06 | $0.00 10-Q · filed 2024-11-06 | ||
| 2023-07-02 | $0.00 10-Q · filed 2024-08-06 | $0.00 10-Q · filed 2024-08-06 | |||
| 2023-04-02 | $0.00 10-Q · filed 2024-05-07 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Avantor, Inc. (AVTR) | United States | $10.501B | -9.72 |
| BRUKER CORP (BRKR) | United States | $9.706B | -128.75 |
| METTLER TOLEDO INTERNATIONAL INC/ (MTD) | $30.436B | 30.62 | |
| Alamar Biosciences, Inc. (ALMR) | United States | $2.300B | |
| Cytek Biosciences, Inc. (CTKB) | United States | $0.744B | -7.15 |
| PACIFIC BIOSCIENCES OF CALIFORNIA, INC. (PACB) | United States | $0.491B | -3.95 |
| 908 Devices Inc. (MASS) | United States | $0.476B | -9.53 |
| EyePoint, Inc. (EYPT) | United States | $0.314B | -3.96 |
| Quanterix Corp (QTRX) | United States | $0.150B | -1.65 |
| Nautilus Biotechnology, Inc. (NAUT) | United States | $0.129B | -4.16 |